Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
8.26B
Market cap8.26B
Price-Earnings ratio
-107.92
Price-Earnings ratio-107.92
Dividend yield
Dividend yield
Average volume
1.37M
Average volume1.37M
High today
$169.00
High today$169.00
Low today
$165.21
Low today$165.21
Open price
$167.17
Open price$167.17
Volume
1.68M
Volume1.68M
52 Week high
$203.01
52 Week high$203.01
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $167.81. The company's market cap stands at 8.26B, with a P/E ratio of -107.92.

On 2025-11-15, Charles River(CRL) stock moved within a range of $165.21 to $169.00. With shares now at $167.81, the stock is trading +1.6% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 1.68M, compared to an average daily volume of 1.37M.

The stock's 52-week range extends from a low of $91.86 to a high of $203.01.

The stock's 52-week range extends from a low of $91.86 to a high of $203.01.

CRL News

Simply Wall St 3d
Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' Investment Narrative?

On November 5, 2025, Charles River Laboratories International reported a year-over-year decrease in revenue and net income for the third quarter, alongside lowe...

Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' Investment Narrative?
Nasdaq 3d
Wednesday Sector Leaders: Healthcare, Financial

The best performing sector as of midday Wednesday is the Healthcare sector, higher by 1.4%. Within that group, Charles River Laboratories International Inc. (Sy...

Wednesday Sector Leaders: Healthcare, Financial
TipRanks 5d
Charles River price target raised to $185 from $170 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Charles River (CRL) to $185 from $170 and keeps an Equal Weight rating on the shares. Meet Your ETF AI Analyst...

Analyst ratings

47%

of 19 ratings
Buy
47.4%
Hold
47.4%
Sell
5.3%

More CRL News

Simply Wall St 6d
Charles River Labs: Assessing Valuation After Analyst Upgrade, Earnings Beat, Divestitures, and $1B Buyback Announcement

Charles River Laboratories (CRL) caught the market’s eye following Baird’s recent upgrade. The company also reported an earnings beat, announced asset divestitu...

Charles River Labs: Assessing Valuation After Analyst Upgrade, Earnings Beat, Divestitures, and $1B Buyback Announcement

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.